A study evaluating effect of elagolix on pharmacokinetic of midazolam.

Trial Profile

A study evaluating effect of elagolix on pharmacokinetic of midazolam.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Elagolix (Primary) ; Midazolam
  • Indications Endometriosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2017 New trial record
    • 01 Sep 2017 Results of a analysis assessing impact of elagolix on pharmacokinetics of midazolam using patient data from two clinical trials (see CTPs 288966 and 288967) published in the Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top